December 16, 2019 · STOCK Act disclosure
Representative Josh Gottheimer (Democrat-NJ) bought BioMarin Pharmaceutical Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on December 16, 2019 and was disclosed on January 6, 2020 (owner: Joint). Members of Congress must report such transactions within 45 days under the STOCK Act.